SEQUENTIAL CHEMOTHERAPY WITH GEMCITABINE plus CARBOPLATIN FOLLOWED BY GEMCITABINE plus CARBOPLATIN plus DOCETAXEL FOR ADVANCED UPPER-TRACT UROTHELIAL CANCER

被引：0
|
作者：
Yoneyama, Takahiro
Ishibashi, Yuusuke
Okamoto, Teppei
Suzuki, Yuuichirou
Tobisawa, Yuuki
Yoneyama, Toru
Okamoto, Akiko
Yamamoto, Hayato
Imai, Atsushi
Hatakeyama, Shingo
Mori, Kazuyuki
Hashimoto, Yasuhiro
Koie, Takuya
Kamimura, Noritaka
Ohyama, Chikara
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.608
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
535
引用
收藏
页码：E220 / E220
页数：1
相关论文
共 50 条
  • [21] Gemcitabine/carboplatin in advanced urothelial cancer
    Carles, J
    Nogué, M
    SEMINARS IN ONCOLOGY, 2001, 28 (03) : 19 - 24
  • [22] Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis
    Mofid, Bahram
    Razzaghdoust, Abolfazl
    Ghajari, Mahdi
    Basiri, Abbas
    Fattahi, Mohammad-Reza
    Houshyari, Mohammad
    Jafari, Anya
    Taghizadeh-Hesary, Farzad
    UROLOGY JOURNAL, 2022, 19 (05) : 371 - 378
  • [23] Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma
    Miyake, Makito
    Shimizu, Takuto
    Nishimura, Nobutaka
    Kiba, Keisuke
    Maesaka, Fumisato
    Oda, Yuki
    Tachibana, Akira
    Tomizawa, Mitsuru
    Ohmori, Chihiro
    Matsumura, Yoshiaki
    Ichikawa, Kazuki
    Mizobuchi, Shinichiro
    Yoshikawa, Takanosuke
    Hori, Shunta
    Morizawa, Yosuke
    Gotoh, Daisuke
    Nakai, Yasushi
    Anai, Satoshi
    Torimoto, Kazumasa
    Aoki, Katsuya
    Tanaka, Nobumichi
    Fujimoto, Kiyohide
    CLINICAL GENITOURINARY CANCER, 2022, 20 (02) : 196.e1 - 196.e9
  • [24] Weekly Carboplatin/Gemcitabine plus Concurrent Thoracic RT Followed by Consolidation Carboplatin/Gemcitabine for Inoperable Stage III NSCLC
    Domine, Manuel
    Carames, Cristina
    Lobo, Francisco
    Hernandez Guerrero, Tatiana
    Leon, Ana
    Casado, Victoria
    Rubio, Gustavo
    Moreno, Irene
    Martin Valades, Jose Ignacio
    Lzarzugaza, Yann
    Luis Arranz, Juan
    Moreno, Victor
    Correa, Andrea
    Zenzola, Victor
    Casado, Susana
    Ruperez, Ana
    Hernandez, Roberto
    Garcia-Foncillas, Jesus
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S445 - S445
  • [25] Neoadjuvant chemotherpay with gemcitabine plus carboplatin in advanced and unresectable gastric cancer.
    Leoner, C
    Mora, J
    Delgadillo, F
    Gallardo, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 373S - 373S
  • [26] Gemcitabine plus split-dose cisplatin could be a promising alternative to gemcitabine plus carboplatin for cisplatin-unfit patients with advanced urothelial carcinoma
    Kim, Yi Rang
    Lee, Jae Lyun
    You, Dalsan
    Jeong, In Gab
    Song, Cheryn
    Hong, Bumsik
    Hong, Jun Hyuk
    Ahn, Hanjong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (01) : 141 - 153
  • [27] Gemcitabine plus split-dose cisplatin could be a promising alternative to gemcitabine plus carboplatin for cisplatin-unfit patients with advanced urothelial carcinoma
    Yi Rang Kim
    Jae Lyun Lee
    Dalsan You
    In Gab Jeong
    Cheryn Song
    Bumsik Hong
    Jun Hyuk Hong
    Hanjong Ahn
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 141 - 153
  • [28] Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors
    Galsky, Matthew D.
    Posner, Marshall
    Holcombe, Randall F.
    Lee, Karen M.
    Misiukiewicz, Krzysztof
    Tsao, Che-Kai
    Godbold, James
    Soto, Rothschild
    Gimpel-Tetra, Kiev
    Lowe, Nancy
    Oh, William K.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (03) : 465 - 471
  • [29] Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors
    Matthew D. Galsky
    Marshall Posner
    Randall F. Holcombe
    Karen M. Lee
    Krzysztof Misiukiewicz
    Che-Kai Tsao
    James Godbold
    Rothschild Soto
    Kiev Gimpel-Tetra
    Nancy Lowe
    William K. Oh
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 465 - 471
  • [30] Pemetrexed plus gemcitabine versus gemcitabine plus carboplatin in patients with advanced nanoperable NSCLC: A randomized phase II study
    Hillerdal, G. N.
    Koyi, H.
    Branden, E.
    Kolbeck, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345